CCR5 gene expression in fulminant hepatitis and DTH in mice

World Journal of Gastroenterology

Volumn 4, Issue 1-6, 1998, Pages 14-18

  Guo, Bao Yu ^a,c   Zhang, Su Ying ^a   Mukaida, Naofumi ^b   Harada, Akihisa ^b   Kuno, Kouji ^b   Wang, Jian Bin ^b   Sun, Shu Han ^a   Matsushima, Kouji ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KANAZAWA UNIVERSITY   (Japan)

^c Second Military Medical University ^*  (China)

Author keywords

CCR5 gene; Cloning, molecular; Disease models, animal; DNA, complementary; Gene expression; Hepatitis; Hypersensitivity, delayed; Immunohistochemistry; Polymerase chain reaction

Indexed keywords

EID: 0002993354     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v4.i1.14     Document Type: Article

References (15)

1. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M. Identification of a major co-receptor for primary isolates of HIV-1. Nature, 1996;381(6584):661 -666
2. + cells is mediated by the receptor CC-CKR-5. Nature, 1996;381 (6584):667-673
3. Samson M, Libretto F, Doranz BJ, Rocker J, Liesnard C, Farmer CM. Resistance, to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 receptor gene. Nature, 1996;382(6593):722-725
4. + T cells. Science, 1995;270(5243):1811 -1815
5. + lymphocytes from persons who remain despite multiple high-risk sexual exposure. Nat Med, 1996; 2(4): 412-417
6. Choe H, Farzan M, Sun Y, Sultan N, Rollins B, Ponath PD. The beta-receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 1996;85 (7):1135-1148
7. Chen C, and Okayama H. High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol, 1987;7:2745-2749
8. Morohashi H, Miyawaki T, Normura H, Kuno K, Murakami S, Matsushima K. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Biol, 1995;57(1):180-187
9. Nomura H, Nielsen BW, Matsushima K. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Intern Immunol, 1993;5(10):1239-1249
10. Pour F, Melon S, Coffinur RL. Interleukin-4 and interleukin-10 to inhibit cell-mediated immunity in vivo. Er J Immunol, 1993;23(11):3043-3049
11. Devergne O, Marring-Choke A, Schall TJ, Leger-Raft MB, Sadick M, Peuchmaur M. Production of the RANTES in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med, 1994;179(5):1689-1694
12. +) in classical delayed-type ( tuberculin) hypersensitivity reactions in human skin. J Immunol, 1992;148(7):2058-2061
13. Devergne O, Emilie D, Peuchmaur M, Craven MC, Agay MF, Galanaud P. Production of cytokines in sacred lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes. Hum Patrol, 1992;23(3): 317-323
14. Heinzl FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of evidence for expansion of distinct helper T cell subsets. J Exp Med, 1989;169(1):59-72
15. Sadick MD, Heinzl FP, Holiday BJ, Pu RT, Dawns RS, Locksley RM. Cure of mourn with anti-interleukin 4 monoclonal antibody evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med, 1990;171 (1):115-127